Cargando…
Combined Sabal and Urtica Extracts (WS(®) 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia
WS(®) 1541 is a phytopharmaceutical drug combination containing a lipophilic extract from fruits of Sabal serrulata (WS(®) 1473) and an aqueous ethanolic extract from roots of Urtica dioica (WS(®) 1031). It is approved in several countries worldwide for the treatment of lower urinary tract syndrome...
Autores principales: | Pigat, Natascha, Reyes-Gomez, Edouard, Boutillon, Florence, Palea, Stefano, Barry Delongchamps, Nicolas, Koch, Egon, Goffin, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450068/ https://www.ncbi.nlm.nih.gov/pubmed/30984003 http://dx.doi.org/10.3389/fphar.2019.00311 |
Ejemplares similares
-
WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
por: Kirschner-Hermanns, Ruth, et al.
Publicado: (2019) -
STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice
por: Boutillon, Florence, et al.
Publicado: (2019) -
Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia
por: Jin, Bo-Ram, et al.
Publicado: (2018) -
High Milk Consumption Does Not Affect Prostate Tumor Progression in Two Mouse Models of Benign and Neoplastic Lesions
por: Bernichtein, Sophie, et al.
Publicado: (2015) -
Green-synthesized zinc oxide nanoparticles, anti-Alzheimer potential and the metabolic profiling of Sabal blackburniana grown in Egypt supported by molecular modelling
por: El-Hawwary, Seham S., et al.
Publicado: (2021)